NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|442620123|ref|NP_001262773|]
View 

neprilysin 4, isoform C [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
212-976 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 772.69  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 212 VDPCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEKNtpvhsaaelrkspvrntlfklneqgegegeA 291
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEA------------------------------A 50
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 292 DQAAELTAERlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeeaappvvlpkdktkdksdneeqlhvptd 371
Cdd:cd08662   51 SSAADSSAEQ---------------------------------------------------------------------- 60
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 372 flkphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTLIRELGGWPVLEsqwsesNFNWQVLAATLRRYNNDILIVQWVGAD 451
Cdd:cd08662   61 ----------KAKDFYKSCMDEEAIEKLGLKPLKPLLDKIGGLPSLD------DLAAELLLALLRRLGVSLLFGLGVSPD 124
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 452 IKNSEENIVQFDQTGLGLPTREYFLQPSNAKYLQAYQRYMAEVMHKMGASKADAQRVASELVAFETQLAGITAPAEQRLN 531
Cdd:cd08662  125 PKNSSRNILYLGQPGLGLPDRDYYLDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRD 204
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 532 VTKLYKRMTLDQLQAVVPEIKWRAYLQSLQDrEVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWRFVRHRINNVD 611
Cdd:cd08662  205 PEKTYNPLTLAELQKLAPSIDWKAYLKALGP-PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLS 283
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 612 DRFDDIKQSFYHALFGREESPQRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRDILKTTDWLDDT 691
Cdd:cd08662  284 KEFRDARFFYGKALSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEE 363
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 692 TKQLAEEKVNAMSLKIGYPDFILNPSELNSKYAGIEIyPEKYFENTLNVLLHTAKTEQAKLHERVNKTNWQTAPAIVNAY 771
Cdd:cd08662  364 TKKKALEKLDAMKVKIGYPDKWRDYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAY 442
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 772 YSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSSIRGFDERARCIIAQ 851
Cdd:cd08662  443 YNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQ 522
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 852 YSNYTVEEvGIVLNGESTQGENIADNGGLRQAFHAYQRWLKEHPsevsDEILPGLNMTGPQLFFLNFGQVWCGAMRPEAI 931
Cdd:cd08662  523 YSNYEVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENG----PELPGLEGFTPEQLFFLSFAQVWCSKYRPEAL 597
                        730       740       750       760
                 ....*....|....*....|....*....|....*....|....*
gi 442620123 932 RNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPMNPQKKCS 976
Cdd:cd08662  598 RQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
212-976 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 772.69  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 212 VDPCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEKNtpvhsaaelrkspvrntlfklneqgegegeA 291
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEA------------------------------A 50
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 292 DQAAELTAERlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeeaappvvlpkdktkdksdneeqlhvptd 371
Cdd:cd08662   51 SSAADSSAEQ---------------------------------------------------------------------- 60
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 372 flkphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTLIRELGGWPVLEsqwsesNFNWQVLAATLRRYNNDILIVQWVGAD 451
Cdd:cd08662   61 ----------KAKDFYKSCMDEEAIEKLGLKPLKPLLDKIGGLPSLD------DLAAELLLALLRRLGVSLLFGLGVSPD 124
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 452 IKNSEENIVQFDQTGLGLPTREYFLQPSNAKYLQAYQRYMAEVMHKMGASKADAQRVASELVAFETQLAGITAPAEQRLN 531
Cdd:cd08662  125 PKNSSRNILYLGQPGLGLPDRDYYLDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRD 204
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 532 VTKLYKRMTLDQLQAVVPEIKWRAYLQSLQDrEVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWRFVRHRINNVD 611
Cdd:cd08662  205 PEKTYNPLTLAELQKLAPSIDWKAYLKALGP-PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLS 283
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 612 DRFDDIKQSFYHALFGREESPQRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRDILKTTDWLDDT 691
Cdd:cd08662  284 KEFRDARFFYGKALSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEE 363
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 692 TKQLAEEKVNAMSLKIGYPDFILNPSELNSKYAGIEIyPEKYFENTLNVLLHTAKTEQAKLHERVNKTNWQTAPAIVNAY 771
Cdd:cd08662  364 TKKKALEKLDAMKVKIGYPDKWRDYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAY 442
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 772 YSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSSIRGFDERARCIIAQ 851
Cdd:cd08662  443 YNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQ 522
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 852 YSNYTVEEvGIVLNGESTQGENIADNGGLRQAFHAYQRWLKEHPsevsDEILPGLNMTGPQLFFLNFGQVWCGAMRPEAI 931
Cdd:cd08662  523 YSNYEVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENG----PELPGLEGFTPEQLFFLSFAQVWCSKYRPEAL 597
                        730       740       750       760
                 ....*....|....*....|....*....|....*....|....*
gi 442620123 932 RNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPMNPQKKCS 976
Cdd:cd08662  598 RQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
207-978 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 570.94  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 207 YMDNKVDPCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEkntpvhsaaelrkspvrntlfklneqge 286
Cdd:COG3590   32 NMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILE---------------------------- 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 287 gegeadqaaeltaerlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeEAAppvvlpkdKTKDKSDNEEQl 366
Cdd:COG3590   84 ---------------------------------------------------------EAA--------AAPAAAGSDEQ- 97
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 367 hvptdflkphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTL---IRELGGWPVLesqwsesnfnwQVLAATLRRYNNDIL 443
Cdd:COG3590   98 ---------------KIGDLYASFMDEAAIEALGLAPLKPDlarIDAIKDKADL-----------AALLAALHRAGVGGL 151
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 444 IVQWVGADIKNSEENIVQFDQTGLGLPTREYFLQ--PSNAKYLQAYQRYMAEVMHKMGASKADAQRVASELVAFETQLAG 521
Cdd:COG3590  152 FGFGVDADLKNSTRYIAYLGQGGLGLPDRDYYLKddEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAK 231
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 522 ITAPAEQRLNVTKLYKRMTLDQLQAVVPEIKWRAYLQSLQdreVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWR 601
Cdd:COG3590  232 AHWSRVELRDPEKTYNPMTVAELAKLAPGFDWDAYLKALG---LPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWH 308
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 602 FVRHRINNVDDRFDDIKQSFY-HALFGREESPQRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRD 680
Cdd:COG3590  309 LLDSAAPYLSKAFVDANFDFYgKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRE 388
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 681 ILKTTDWLDDTTKQLAEEKVNAMSLKIGYPDfilnpselnsK---YAGIEIYPEKYFENTLNVLLHTAKTEQAKLHERVN 757
Cdd:COG3590  389 RIENLDWMSPETKAKALEKLAAFTPKIGYPD----------KwrdYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVD 458
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 758 KTNWQTAPAIVNAYYSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSS 837
Cdd:COG3590  459 RTEWGMTPQTVNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPED 538
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 838 IRGFDERARCIIAQYSNYTVEEvGIVLNGESTQGENIADNGGLRQAFHAYQRWLKEHPSEVSDeilpGLnmTGPQLFFLN 917
Cdd:COG3590  539 RAAFEARTKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAPVID----GF--TGDQRFFLG 611
                        730       740       750       760       770       780
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 442620123 918 FGQVWCGAMRPEAIRNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPM--NPQKKCSVW 978
Cdd:COG3590  612 WAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
214-710 1.34e-134

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 409.38  E-value: 1.34e-134
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  214 PCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEKntpvhsaaelrkspvrntlfklneqgegegeadq 293
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEE---------------------------------- 46
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  294 aaeltaerlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeeaappvvlPKDKTKDKSDNEeqlhvptdfl 373
Cdd:pfam05649  47 ----------------------------------------------------------AAASESDPGAVE---------- 58
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  374 kphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTLIRELGGWPvlesqWSESNFNWQVLAATLRRYNNDILIVQWVGADIK 453
Cdd:pfam05649  59 --------KAKDLYKSCMDTDAIEKLGLKPLKPLLDEIGGPL-----ANKDKFDLLETLAKLRRYGVDSLFGFGVGPDDK 125
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  454 NSEENIVQFDQTGLGLPTREYFLQPSN---AKYLQAYQRYMAEVMHKMGASkADAQRVASELVAFETQLAGITAPAEQRL 530
Cdd:pfam05649 126 NSSRNILYLDQPGLGLPDRDYYLKDRDeksAEIREAYKAYIAKLLTLLGAS-EEAAALAEEVLAFETKLAKASLSREERR 204
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  531 NVTKLYKRMTLDQLQAVVPEIKWRAYLQSLqDREVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWRFVRHRINNV 610
Cdd:pfam05649 205 DPEKTYNPMTLAELQKLAPGIDWKAYLNAA-GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYL 283
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  611 DDRFDDIKQSFYHALFGREESPqRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRDILKTTDWLDD 690
Cdd:pfam05649 284 SDEFRDANFEFYGTLSGTKQRP-RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDE 362
                         490       500
                  ....*....|....*....|
gi 442620123  691 TTKQLAEEKVNAMSLKIGYP 710
Cdd:pfam05649 363 ETKKKALEKLDAMTVKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
212-976 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 772.69  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 212 VDPCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEKNtpvhsaaelrkspvrntlfklneqgegegeA 291
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEA------------------------------A 50
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 292 DQAAELTAERlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeeaappvvlpkdktkdksdneeqlhvptd 371
Cdd:cd08662   51 SSAADSSAEQ---------------------------------------------------------------------- 60
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 372 flkphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTLIRELGGWPVLEsqwsesNFNWQVLAATLRRYNNDILIVQWVGAD 451
Cdd:cd08662   61 ----------KAKDFYKSCMDEEAIEKLGLKPLKPLLDKIGGLPSLD------DLAAELLLALLRRLGVSLLFGLGVSPD 124
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 452 IKNSEENIVQFDQTGLGLPTREYFLQPSNAKYLQAYQRYMAEVMHKMGASKADAQRVASELVAFETQLAGITAPAEQRLN 531
Cdd:cd08662  125 PKNSSRNILYLGQPGLGLPDRDYYLDEENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRD 204
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 532 VTKLYKRMTLDQLQAVVPEIKWRAYLQSLQDrEVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWRFVRHRINNVD 611
Cdd:cd08662  205 PEKTYNPLTLAELQKLAPSIDWKAYLKALGP-PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLS 283
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 612 DRFDDIKQSFYHALFGREESPQRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRDILKTTDWLDDT 691
Cdd:cd08662  284 KEFRDARFFYGKALSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEE 363
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 692 TKQLAEEKVNAMSLKIGYPDFILNPSELNSKYAGIEIyPEKYFENTLNVLLHTAKTEQAKLHERVNKTNWQTAPAIVNAY 771
Cdd:cd08662  364 TKKKALEKLDAMKVKIGYPDKWRDYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAY 442
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 772 YSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSSIRGFDERARCIIAQ 851
Cdd:cd08662  443 YNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQ 522
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 852 YSNYTVEEvGIVLNGESTQGENIADNGGLRQAFHAYQRWLKEHPsevsDEILPGLNMTGPQLFFLNFGQVWCGAMRPEAI 931
Cdd:cd08662  523 YSNYEVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENG----PELPGLEGFTPEQLFFLSFAQVWCSKYRPEAL 597
                        730       740       750       760
                 ....*....|....*....|....*....|....*....|....*
gi 442620123 932 RNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPMNPQKKCS 976
Cdd:cd08662  598 RQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
207-978 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 570.94  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 207 YMDNKVDPCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEkntpvhsaaelrkspvrntlfklneqge 286
Cdd:COG3590   32 NMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILE---------------------------- 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 287 gegeadqaaeltaerlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeEAAppvvlpkdKTKDKSDNEEQl 366
Cdd:COG3590   84 ---------------------------------------------------------EAA--------AAPAAAGSDEQ- 97
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 367 hvptdflkphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTL---IRELGGWPVLesqwsesnfnwQVLAATLRRYNNDIL 443
Cdd:COG3590   98 ---------------KIGDLYASFMDEAAIEALGLAPLKPDlarIDAIKDKADL-----------AALLAALHRAGVGGL 151
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 444 IVQWVGADIKNSEENIVQFDQTGLGLPTREYFLQ--PSNAKYLQAYQRYMAEVMHKMGASKADAQRVASELVAFETQLAG 521
Cdd:COG3590  152 FGFGVDADLKNSTRYIAYLGQGGLGLPDRDYYLKddEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAK 231
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 522 ITAPAEQRLNVTKLYKRMTLDQLQAVVPEIKWRAYLQSLQdreVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWR 601
Cdd:COG3590  232 AHWSRVELRDPEKTYNPMTVAELAKLAPGFDWDAYLKALG---LPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWH 308
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 602 FVRHRINNVDDRFDDIKQSFY-HALFGREESPQRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRD 680
Cdd:COG3590  309 LLDSAAPYLSKAFVDANFDFYgKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRE 388
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 681 ILKTTDWLDDTTKQLAEEKVNAMSLKIGYPDfilnpselnsK---YAGIEIYPEKYFENTLNVLLHTAKTEQAKLHERVN 757
Cdd:COG3590  389 RIENLDWMSPETKAKALEKLAAFTPKIGYPD----------KwrdYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVD 458
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 758 KTNWQTAPAIVNAYYSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSS 837
Cdd:COG3590  459 RTEWGMTPQTVNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPED 538
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123 838 IRGFDERARCIIAQYSNYTVEEvGIVLNGESTQGENIADNGGLRQAFHAYQRWLKEHPSEVSDeilpGLnmTGPQLFFLN 917
Cdd:COG3590  539 RAAFEARTKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGKEAPVID----GF--TGDQRFFLG 611
                        730       740       750       760       770       780
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 442620123 918 FGQVWCGAMRPEAIRNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPM--NPQKKCSVW 978
Cdd:COG3590  612 WAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
214-710 1.34e-134

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 409.38  E-value: 1.34e-134
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  214 PCVDFYKYACGNWERLHPIPKDKAGFDTFEMLRESLDLVLRNLLEKntpvhsaaelrkspvrntlfklneqgegegeadq 293
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEE---------------------------------- 46
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  294 aaeltaerlrrhivskrqllnrvlvrykrytngtkrkrlietprertkeeeaappvvlPKDKTKDKSDNEeqlhvptdfl 373
Cdd:pfam05649  47 ----------------------------------------------------------AAASESDPGAVE---------- 58
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  374 kphqdaqlKAKNLYRSCVNSAVLAKRGLEPLHTLIRELGGWPvlesqWSESNFNWQVLAATLRRYNNDILIVQWVGADIK 453
Cdd:pfam05649  59 --------KAKDLYKSCMDTDAIEKLGLKPLKPLLDEIGGPL-----ANKDKFDLLETLAKLRRYGVDSLFGFGVGPDDK 125
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  454 NSEENIVQFDQTGLGLPTREYFLQPSN---AKYLQAYQRYMAEVMHKMGASkADAQRVASELVAFETQLAGITAPAEQRL 530
Cdd:pfam05649 126 NSSRNILYLDQPGLGLPDRDYYLKDRDeksAEIREAYKAYIAKLLTLLGAS-EEAAALAEEVLAFETKLAKASLSREERR 204
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  531 NVTKLYKRMTLDQLQAVVPEIKWRAYLQSLqDREVLGTEEVVIYAVEYMSKLVTLLDETDPRTVSNYMMWRFVRHRINNV 610
Cdd:pfam05649 205 DPEKTYNPMTLAELQKLAPGIDWKAYLNAA-GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYL 283
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  611 DDRFDDIKQSFYHALFGREESPqRWKVCIAQVNTNMGMAVGSMFVSRYFDNNSKRDTLRMTHDLQQAFRDILKTTDWLDD 690
Cdd:pfam05649 284 SDEFRDANFEFYGTLSGTKQRP-RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDE 362
                         490       500
                  ....*....|....*....|
gi 442620123  691 TTKQLAEEKVNAMSLKIGYP 710
Cdd:pfam05649 363 ETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
769-977 1.63e-75

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 246.56  E-value: 1.63e-75
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  769 NAYYSRNKNQIMFPAGILQPPFYHRHFPKSLNFGGIGVVIGHELTHGFDDKGRLFDRNGNIHKWWTDSSIRGFDERARCI 848
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442620123  849 IAQYSNYTVEEVGIVLNGESTQGENIADNGGLRQAFHAYQRwLKEHPSEVsdeiLPGL-NMTGPQLFFLNFGQVWCGAMR 927
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKK-LLSANETV----LPGFeNLTPDQLFFRGAAQIWCMKQS 155
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|
gi 442620123  928 PEAIRNKLNTAIHSPGRFRVIGTLSNSVDFAREFNCPLGSPMNPQKKCSV 977
Cdd:pfam01431 156 PAEVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
765-821 1.16e-04

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 42.09  E-value: 1.16e-04
                         10        20        30        40        50
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 442620123 765 PAIVNAYYSrNKNQIMFPAGILQppfyhrhfpkslNFGGIGVVIGHELTHGFDDKGR 821
Cdd:cd09594   39 VNAYNAMWI-PSTNIFYGAGILD------------TLSGTIDVLAHELTHAFTGQFS 82
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH